Evidence map›Paper›PMID 18165904›Full record

ReviewReviews in endocrine & metabolic disorders2008

Chronic pediatric inflammatory diseases: effects on bone.

Anuradha Viswanathan, Francisco A Sylvester

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Reviews in endocrine & metabolic disorders, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06216704 (Skeletal Health and Bone Marrow Composition in Adolescents With Cystic Fibrosis), which is not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06216704 recruitingnot on this mapstarted 2024, after this paper: background citation

Skeletal Health and Bone Marrow Composition in Adolescents With Cystic Fibrosis

TypeobservationalSponsorMassachusetts General HospitalRan2024 to 2029Enrolled36ConditionsCystic FibrosisArmsMagnetic resonance relaxometry, Magnetic resonance spectroscopy, Blood Draw, DXA, pQCT
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Bone impairment assessed by HR-pQCT in juvenile-onset systemic lupus erythematosus.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2016
    Article
  3. Is it necessary to screen for celiac disease in adult idiopathic osteoporosis?Gastroenterology and hepatology from bed to bench · 2015
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. The impact of inflammation on bone mass in children.Pediatric nephrology (Berlin, Germany) · 2011
    Review
  9. Article
  10. Article
  11. Smurf control in bone cells.Journal of cellular biochemistry · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Anuradha ViswanathanUniversity of Connecticut School of Medicine, Farmington, CT, USA. Aviswanathan@ccmckids.org
Francisco A Sylvester
Connecticut Children's Medical Center · USUniversity of Connecticut · US

Funding

Mechanisms of Bone Loss in Pediatric Crohn DiseaseR01DK066303 · NIDDK · ST. FRANCIS HOSPITAL AND MEDICAL CENTER · PI SYLVESTER, FRANCISCO A · 2004 to 2008
$1.0M
NIDDK NIH HHS R01 DK066303
6 · The paper itself

Abstract

In children, chronic inflammatory diseases present a significant challenge to long-term skeletal health. These conditions are often associated with poor appetite and suboptimal overall nutrition, altered nutrient utilization, delayed puberty, inactivity, and reduced muscle mass, all of which can alter bone metabolism. In addition, bone cell activity is susceptible to the effects of the immune response that characterizes these diseases. Moreover, drugs used to treat these maladies, notably glucocorticoids, may have negative effects on bone formation and on linear growth in developing children. As a result, predicted peak bone mass may not be achieved, and fracture risk may be increased in the short term or in the future. Studies using primarily dual energy X-ray absorptiometry have documented that deficits in bone mass are common in these diseases. However, there are wide variations in the prevalence of low bone mass, largely due to differences in the characteristics of each study population. Recent studies provide insight into the pathogenesis of decreased bone mass in these conditions. In this paper we will provide an overview of the effects of chronic inflammatory conditions on bone mass in children. We will also present relevant data from adult patients, when pediatric data are scant or not available.

Indexed as

Bone and BonesBone DensityBone DiseasesChronic DiseaseHumansInflammationOsteoporosis

Identifiers

PMID18165904
OpenAlexW2084827229

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.